Raymond James Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96M Buy
327,935
+69,903
+27% +$526K ﹤0.01% 3375
2025
Q4
$1.85M Sell
258,032
-62,509
-20% -$494K ﹤0.01% 3337
2025
Q3
$3.42M Sell
320,541
-96,149
-23% -$944K ﹤0.01% 2753
2025
Q2
$4.03M Buy
416,690
+98,562
+31% +$1.02M ﹤0.01% 2523
2025
Q1
$4.74M Buy
318,128
+37,018
+13% +$569K ﹤0.01% 2368
2024
Q4
$4.19M Buy
+281,110
New +$4.58M ﹤0.01% 2434

Other funds holding OGN

Raymond James Financial's OGN Position: Q1 2026 in Review

Raymond James Financial increased its Organon & Co (OGN) stake by 27% in Q1 2026, buying an estimated $526K and bringing the position to 327,935 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3375.

Raymond James Financial first reported a position in OGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.74M in Q1 2025. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Raymond James Financial held 327,935 shares of Organon & Co worth $1.96M as of Q1 2026.
  • Raymond James Financial bought 69,903 Organon & Co shares in Q1 2026, an estimated $526K.
  • Organon & Co made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3375 holding.
  • Raymond James Financial first reported a position in Organon & Co in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Organon & Co position peaked at $4.74M in Q1 2025.
  • 606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.